Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Oncogene

Showing results (1371-1380 of 22,015) with videos related to

Pageof 2,202
Sort By:
Oncogene|May 2, 2018
A kinome-wide high-content siRNA screen identifies MEK5-ERK5 signaling as critical for breast cancer cell EMT and metastasisSimona Pavan, Nathalie Meyer-Schaller, Maren Diepenbruck, et al.
Oncogene|February 25, 1999
Role of hypoxia-induced Bax translocation and cytochrome c release in reoxygenation injuryP Saikumar, Z Dong, Y Patel, et al.
Oncogene|February 25, 1999
Isolation and characterization of a human homologue of the latrophilin gene from a region of 1p31.1 implicated in breast cancerG R White, J M Varley, J Heighway
Oncogene|February 19, 1999
The human F box protein beta-Trcp associates with the Cul1/Skp1 complex and regulates the stability of beta-cateninE Latres, D S Chiaur, M Pagano
Oncogene|February 19, 1999
Downregulation of metallothionein-IIA expression occurs at immortalizationE L Duncan, R R Reddel
Oncogene|February 19, 1999
Thyroid hormone effects on Krox-24 transcription in the post-natal mouse brain are developmentally regulated but are not correlated with mitosisM T Ghorbel, I Seugnet, N Hadj-Sahraoui, et al.
Oncogene|February 19, 1999
Molecular mechanisms of constitutive NF-kappaB/Rel activation in Hodgkin/Reed-Sternberg cellsD Krappmann, F Emmerich, U Kordes, et al.
Oncogene|February 19, 1999
Correlation between the status of the p53 gene and survival in patients with stage I non-small cell lung carcinomaY Tomizawa, T Kohno, T Fujita, et al.
Oncogene|February 19, 1999
Three distinct domains in TEL-AML1 are required for transcriptional repression of the IL-3 promoterH Uchida, J R Downing, Y Miyazaki, et al.
Oncogene|February 19, 1999
Retinoic acid, but not arsenic trioxide, degrades the PLZF/RARalpha fusion protein, without inducing terminal differentiation or apoptosis, in a RA-therapy resistant t(11;17)(q23;q21) APL patientM H Koken, M T Daniel, M Gianni, et al.
Pageof 2,202

Showing results (1371-1380 of 22,015) with videos related to

Sort By:
Pageof 2,202
Oncogene|May 2, 2018
A kinome-wide high-content siRNA screen identifies MEK5-ERK5 signaling as critical for breast cancer cell EMT and metastasisSimona Pavan, Nathalie Meyer-Schaller, Maren Diepenbruck, et al.
Oncogene|February 25, 1999
Role of hypoxia-induced Bax translocation and cytochrome c release in reoxygenation injuryP Saikumar, Z Dong, Y Patel, et al.
Oncogene|February 25, 1999
Isolation and characterization of a human homologue of the latrophilin gene from a region of 1p31.1 implicated in breast cancerG R White, J M Varley, J Heighway
Oncogene|February 19, 1999
The human F box protein beta-Trcp associates with the Cul1/Skp1 complex and regulates the stability of beta-cateninE Latres, D S Chiaur, M Pagano
Oncogene|February 19, 1999
Downregulation of metallothionein-IIA expression occurs at immortalizationE L Duncan, R R Reddel
Oncogene|February 19, 1999
Thyroid hormone effects on Krox-24 transcription in the post-natal mouse brain are developmentally regulated but are not correlated with mitosisM T Ghorbel, I Seugnet, N Hadj-Sahraoui, et al.
Oncogene|February 19, 1999
Molecular mechanisms of constitutive NF-kappaB/Rel activation in Hodgkin/Reed-Sternberg cellsD Krappmann, F Emmerich, U Kordes, et al.
Oncogene|February 19, 1999
Correlation between the status of the p53 gene and survival in patients with stage I non-small cell lung carcinomaY Tomizawa, T Kohno, T Fujita, et al.
Oncogene|February 19, 1999
Three distinct domains in TEL-AML1 are required for transcriptional repression of the IL-3 promoterH Uchida, J R Downing, Y Miyazaki, et al.
Oncogene|February 19, 1999
Retinoic acid, but not arsenic trioxide, degrades the PLZF/RARalpha fusion protein, without inducing terminal differentiation or apoptosis, in a RA-therapy resistant t(11;17)(q23;q21) APL patientM H Koken, M T Daniel, M Gianni, et al.
Pageof 2,202